2021 | Ferroportin and FBXL5 as Prognostic Markers in Advanced Stage Clear Cell Renal Cell Carcinoma
| CANCER RESEARCH AND TREATMENT |
2016 | Fibroblast Growth Factor Receptor 1 Overexpression Is Associated with Poor Survival in Patients with Resected Muscle Invasive Urothelial Carcinoma.
| YONSEI MEDICAL JOURNAL |
2008 | Gene amplification and mutation analysis of epidermal growth factor receptor in hormone refractory prostate cancer | PROSTATE |
2007 | Giant Multilocular Prostatic Cystadenoma Presenting with Obstructive Aspermia
| YONSEI MEDICAL JOURNAL |
2007 | Grade of Hydronephrosis and Tumor Diameter as Preoperative Prognostic Factors in Ureteral Transitional Cell Carcinoma | UROLOGY |
2018 | HSP27, ALDH6A1 and Prohibitin Act as a Trio-biomarker to Predict Survival in Late Metastatic Prostate Cancer | ANTICANCER RESEARCH |
2014 | Impact of charlson comorbidity index varies by age in patients with prostate cancer treated by radical prostatectomy: A competing risk regression analysis | ANNALS OF SURGICAL ONCOLOGY |
2017 | Impact of lymphovascular invasion on lymph node metastasis for patients undergoing radical prostatectomy with negative resection margin
| BMC CANCER |
2012 | In situ identification and localization of IGHA2 in the breast tumor microenvironment by mass spectrometry | JOURNAL OF PROTEOME RESEARCH |
2003 | Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma | EUROPEAN UROLOGY |
2013 | Inhibition of tumor growth and histopathological changes following treatment with a chemokine receptor CXCR4 antagonist in a prostate cancer xenograft model
| ONCOLOGY LETTERS |
2005 | Juvenile prostatic hyperplasia | UROLOGY |
2015 | Leiomyosarcoma: investigation of prognostic factors for risk-stratification model | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY |
2005 | Loss of Cyclin B1 followed by downregulation of Cyclin A/Cdk2, apoptosis and antiproliferation in Hela cell line | INTERNATIONAL JOURNAL OF CANCER |
2005 | Lymphovascular and marginal invasion as useful prognostic indicators and the role of c-erbB-2 in patients with male extramammary Paget's disease: A study of 31 patients | JOURNAL OF UROLOGY |
2005 | Malignant glomus tumor of the urinary bladder | ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE |
2007 | Matrix Metalloproteinase Expression in the Recurrence of Superficial Low Grade Bladder Transitional Cell Carcinoma | JOURNAL OF UROLOGY |
2014 | Meta-Analysis of the Relationship between CXCR4 Expression and Metastasis in Prostate Cancer.
| WORLD JOURNAL OF MENS HEALTH |
2021 | Metabolic tumour volume on 18 F-FDG PET/CT predicts extended pathological T stages in patients with renal cell carcinoma at staging
| SCIENTIFIC REPORTS |
2005 | Metastatic extramammary Paget's disease with HER2 amplification to renal cell carcinoma: a unique presentation of cancer in cancer metastasis | HEPATOLOGY |
2016 | MicroRNA alteration and putative target genes in high-grade prostatic intraepithelial neoplasia and prostate cancer: STAT3 and ZEB1 are upregulated during prostate carcinogenesis. | PROSTATE |
2017 | Non-contrast magnetic resonance imaging for bladder cancer: fused high b value diffusion-weighted imaging and T2-weighted imaging helps evaluate depth of invasion | EUROPEAN RADIOLOGY |
2010 | Panel of candidate biomarkers for renal cell carcinoma | JOURNAL OF PROTEOME RESEARCH |
2009 | Pathological effects of prostate cancer correlate with neuroendocrine differentiation and PTEN expression after bicalutamide monotherapy. | JOURNAL OF UROLOGY |
2010 | Pattern of failure in bladder cancer patients treated with radical cystectomy: rationale for adjuvant radiotherapy
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2017 | PI-RADS Version 2: Detection of Clinically Significant Cancer in Patients With Biopsy Gleason Score 6 Prostate Cancer | AMERICAN JOURNAL OF ROENTGENOLOGY |
2017 | PI-RADS version 2: Preoperative role in the detection of normal-sized pelvic lymph node metastasis in prostate cancer | EUROPEAN JOURNAL OF RADIOLOGY |
2017 | PI-RADS version 2: quantitative analysis aids reliable interpretation of diffusion-weighted imaging for prostate cancer | EUROPEAN RADIOLOGY |
2020 | Postoperative biochemical recurrence of pathologically localized high-grade prostate cancer in adjuvant treatment-naïve patients | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY |
2016 | Prediction of biochemical recurrence after radical prostatectomy with PI-RADS version 2 in prostate cancers: initial results | EUROPEAN RADIOLOGY |
2015 | Prediction of Micrometastasis (< 1 cm) to Pelvic Lymph Nodes in Prostate Cancer: Role of Preoperative MRI | AMERICAN JOURNAL OF ROENTGENOLOGY |
2008 | Prognostic impact of peripelvic fat invasion in pT3 renal pelvic transitional cell carcinoma
| JOURNAL OF KOREAN MEDICAL SCIENCE |
2018 | Prognostic implications of polycomb proteins ezh2, suz12, and eed1 and histone modification by H3K27me3 in sarcoma.
| BMC CANCER |
2017 | Prognostic Significance of the Proportion of Ductal Component in Ductal Adenocarcinoma of the Prostate | JOURNAL OF UROLOGY |
2017 | Prognostic Significance of Vas Deferens Invasion After Radical Prostatectomy in Patients with Pathological Stage T3b Prostate Cancer | ANNALS OF SURGICAL ONCOLOGY |
2016 | Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers. | RADIOLOGY |
2021 | Prostate epithelial genes define therapy-relevant prostate cancer molecular subtype
| PROSTATE CANCER AND PROSTATIC DISEASES |
2014 | Renal Pelvic Urothelial Carcinoma With Vena Caval Thrombus Mimicking Renal Cell Carcinoma
| KOREAN JOURNAL OF UROLOGY |
2009 | Reply by the authors : Grade of Hydronephrosis and Tumor Diameter as Preoperative Prognostic Factors in Ureteral Transitional Cell Carcinoma | UROLOGY |
2021 | Revisiting extraprostatic extension based on invasion depth and number for new algorithm for substaging of pT3a prostate cancer
| SCIENTIFIC REPORTS |
2020 | Scale-Up Evaluation of a Composite Tumor Marker Assay for the Early Detection of Renal Cell Carcinoma
| DIAGNOSTICS |
2004 | Solitary fibrous tumor of the urinary bladder
| YONSEI MEDICAL JOURNAL |
2020 | Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells
| YONSEI MEDICAL JOURNAL |
2009 | The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder. | UROLOGIA INTERNATIONALIS |
2016 | Total intraglandular and index tumor volumes predict biochemical recurrence in prostate cancer | VIRCHOWS ARCHIV |
2020 | Transrectal ultrasound-guided targeted biopsy of transition zone prostate cancer under cognitive registration with prebiopsy MRI and sonographic findings | CLINICAL RADIOLOGY |
2005 | 방광 이행상피세포암에 동반된 편평상피분화의 임상적 의미
| KOREAN JOURNAL OF UROLOGY |
2004 | 방광에서 발생한 단일섬유종
| KOREAN JOURNAL OF UROLOGY |
2004 | 방광에서 발생한 악성 근주위세포종
| KOREAN JOURNAL OF UROLOGY |
2004 | 방광이행상피암의 진단에서 요세포검사와 Fluorescence in Situ Hybridization (FISH)의 유용성 비교
| KOREAN JOURNAL OF UROLOGY |
1999 | 방광이행세포암종에서의 Cyclin D1의 표현 | Korean Journal of Urology (대한비뇨기과학회지) |
2006 | 상부요로 이행세포암의 재발 양상 및 예후 인자
| KOREAN JOURNAL OF UROLOGY |
2005 | 신세포암과 연관된 음낭의 유방외 파제씨병
| KOREAN JOURNAL OF UROLOGY |
2006 | 요관 이행세포암에서 수신증 및 종양 직경의 임상적 의의
| KOREAN JOURNAL OF UROLOGY |
2004 | 요막관암의 임상적 특성 및 예후
| KOREAN JOURNAL OF UROLOGY |
2004 | 인체 방광 이행상피세포암에서 p53 및 p73 유전자의 표현
| KOREAN JOURNAL OF UROLOGY |
2004 | 저등급 관상 점액성 신장 종양 1례
| KOREAN JOURNAL OF UROLOGY |
2005 | 저등급 표재성 방광암의 재발에서 Matrix Metalloproteinase 발현의 분석
| KOREAN JOURNAL OF UROLOGY |
1997 | 전립선에 전이된 신세포암 1례
| Korean Journal of Urology (대한비뇨기과학회지) |
2005 | 점액성 낭성 방광 점막하 종양
| KOREAN JOURNAL OF UROLOGY |